Prevention of Alzheimer’s Disease in Chinese Populations: Status, Challenges and Directions Lei FengJ. LiChunbo Li Editorial 21 March 2018 Pages: 90 - 94
Diabetes Mellitus and Cognitive Decline – Prevention Should Not Be Delayed! Alan J. SinclairB. Vellas Editorial 20 February 2018 Pages: 95 - 97
Identifying Better Outcome Measures to Improve Treatment of Agitation in Dementia: A Report from the EU/US/CTAD Task Force Mary SanoM. SotoEU/US/CTAD Task Force members CTAD Task Force Paper 27 March 2018 Pages: 98 - 102
Biomarker and Clinical Trial Design Support for Disease-Modifying Therapies: Report of a Survey of the EU/US: Alzheimer’s Disease Task Force Jeffrey CummingsN. FoxEU/US Alzheimer’ Disease Task Force Brief Report 16 March 2018 Pages: 103 - 109
Minimizing the Sample Sizes of Clinical Trials on Preclinical and Early Symptomatic Stage of Alzheimer Disease J. LuoH. WengChengjie Xiong Brief Report 16 March 2018 Pages: 110 - 119
A Literature Review of Methodologies Used in Randomized Clinical Trials of Agitation in Alzheimer’s Disease Sanjay DubéJ. T. MegerianR. Malamut Brief Report 16 March 2018 Pages: 120 - 133
The Integrated Alzheimer’s Disease Rating Scale (iADRS) Findings from the EXPEDITION3 Trial Alette M. WesselsS. W. AndersenE. R. Siemers Original Research 20 February 2018 Pages: 134 - 136
Adherence to the Mediterranean Diet Is not Related to Beta-Amyloid Deposition: Data from the Women’s Healthy Ageing Project E. HillCassandra SzoekeP. Clifton Original Research 27 February 2018 Pages: 137 - 141
Strong Relationship between Malnutrition and Cognitive Frailty in the Singapore Longitudinal Ageing Studies (SLAS-1 and SLAS-2) L. ChyeK. WeiTze-Pin Ng Original Research 05 December 2017 Pages: 142 - 148
Development of Azeliragon, an Oral Small Molecule Antagonist of the Receptor for Advanced Glycation Endproducts, for the Potential Slowing of Loss of Cognition in Mild Alzheimer’s Disease A. H. BursteinM. SabbaghLarry Altstiel Review 22 March 2018 Pages: 149 - 154
Nanorobots the Future of Neurology: A Perspective on Alzheimer’s Disease Claudie HooperS. Layé Letter to Editor 20 February 2018 Pages: 155 - 156
